These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 1719268)

  • 41. Randomized comparison of combination chemotherapy with etoposide, bleomycin, and either high-dose or standard-dose cisplatin in children and adolescents with high-risk malignant germ cell tumors: a pediatric intergroup study--Pediatric Oncology Group 9049 and Children's Cancer Group 8882.
    Cushing B; Giller R; Cullen JW; Marina NM; Lauer SJ; Olson TA; Rogers PC; Colombani P; Rescorla F; Billmire DF; Vinocur CD; Hawkins EP; Davis MM; Perlman EJ; London WB; Castleberry RP; ;
    J Clin Oncol; 2004 Jul; 22(13):2691-700. PubMed ID: 15226336
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Therapy of advanced ovarian juvenile granulosa cell tumors.
    Schneider DT; Calaminus G; Wessalowski R; Pathmanathan R; Harms D; Göbel U
    Klin Padiatr; 2002; 214(4):173-8. PubMed ID: 12165898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors in metastatic nonseminomatous germ cell tumours.
    Hanson PR; Belitsky P; Millard OH; Lannon SG
    Can J Surg; 1993 Dec; 36(6):537-40. PubMed ID: 7504978
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Germ cell tumors with sarcomatous components: a clinicopathologic and immunohistochemical study of 46 cases.
    Malagón HD; Valdez AM; Moran CA; Suster S
    Am J Surg Pathol; 2007 Sep; 31(9):1356-62. PubMed ID: 17721191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Influence of tumor site and histology on long-term survival in 193 children with extracranial germ cell tumors.
    De Backer A; Madern GC; Pieters R; Haentjens P; Hakvoort-Cammel FG; Oosterhuis JW; Hazebroek FW
    Eur J Pediatr Surg; 2008 Feb; 18(1):1-6. PubMed ID: 18302061
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapy of testicular germ cell tumors. Current status of the MAHO studies].
    Haas RJ; Schmidt P; Göbel U; Harms D
    Klin Padiatr; 1993; 205(4):225-30. PubMed ID: 8397320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
    Kesik V; Ozcan A; Sari E; Guven A; Kismet E; Koseoglu V
    Fetal Pediatr Pathol; 2010; 29(3):127-32. PubMed ID: 20450265
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nondysgerminomatous ovarian tumors: clinical characteristics, treatment, and outcome. A case-controlled study.
    Ghaemmaghami F; Hasanzadeh M; Karimi Zarchi M; Fallahi A
    Int J Surg; 2008 Oct; 6(5):382-6. PubMed ID: 18715834
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The malignant potential of teratomas in infancy and childhood: the MAKEI experiences in non-testicular teratoma and implications for a new protocol.
    Göbel U; Calaminus G; Schneider DT; Koch S; Teske C; Harms D
    Klin Padiatr; 2006; 218(6):309-14. PubMed ID: 17080332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Endodermal sinus tumor (yolk sac tumor)--report of 52 cases and review of the literature of 1224 cases].
    Dong HJ; Huang SZ
    Zhonghua Zhong Liu Za Zhi; 1988 May; 10(3):213-6. PubMed ID: 2464466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinicopathological study of malignant ovarian germ cell tumor].
    Kataoka A; Yakushiji M; Nishida T; Oda T; Kojiro M
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Jun; 41(6):695-701. PubMed ID: 2549132
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
    de la Motte Rouge T; Pautier P; Genestie C; Rey A; Gouy S; Leary A; Haie-Meder C; Kerbrat P; Culine S; Fizazi K; Lhommé C
    Gynecol Oncol; 2016 Sep; 142(3):452-7. PubMed ID: 27401840
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is alpha-fetoprotein decline a prognostic factor of childhood non-seminomatous germ cell tumours? Results of the French TGM95 study.
    Fresneau B; Orbach D; Faure-Conter C; Sudour-Bonnange H; Vérité C; Gandemer V; Pasquet M; Fasola S; Rome A; Raimbault S; Martelli H; Frappaz D; Le Teuff G; Patte C
    Eur J Cancer; 2018 May; 95():11-19. PubMed ID: 29604495
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Characteristics of extracranial malignant germ cell tumours in two age groups of children (0-10 and 10-18 years). Multicentre experiences].
    Drozyńska E; Połczyńska K; Popadiuk S; Niedzwiecki M; Wiśniewski J; Balcerska A; Izycka-Swieszewska E; Bilska K; Balwierz W; Chełmecka L; Chybicka A; Dudeńko I; Karolczyk G; Kowalczyk J; Krawczuk-Rybak M; Kurylak A; Leszczyńska E; Matysiak M; Młynarski W; Pobudejska A; Sobol G; Sońta-Jakimczyk D; Szajdak K; Tredowska-Skoczeń D; Szmyd K; Trelińska J; Urasiński T; Wachowiak J; Wieczorek M; Wiśniewska-Slusarz H; Woźniak S; Woźniak W; Wysocki M
    Med Wieku Rozwoj; 2011; 15(1):16-24. PubMed ID: 21786508
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Ovarian germ cell tumors in children. Management, survival and ovarian prognosis. A report of 75 cases.
    Vaysse C; Delsol M; Carfagna L; Bouali O; Combelles S; Lemasson F; Le Mandat A; Castex MP; Pasquet M; Moscovici J; Guitard J; Pienkowski C; Rubie H; Galinier P; Vaysse P
    J Pediatr Surg; 2010 Jul; 45(7):1484-90. PubMed ID: 20638529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Germ cell tumours of childhood. Report of 170 cases including 59 pure and partial yolk-sac tumours.
    Harms D; Jänig U
    Virchows Arch A Pathol Anat Histopathol; 1986; 409(2):223-39. PubMed ID: 2424170
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Alpha-fetoprotein (AFP) levels in normal children.
    Ohama K; Nagase H; Ogino K; Tsuchida K; Tanaka M; Kubo M; Horita S; Kawakami K; Ohmori M
    Eur J Pediatr Surg; 1997 Oct; 7(5):267-9. PubMed ID: 9402482
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of germ cell tumors in children: approaches to cure.
    Göbel U; Calaminus G; Schneider DT; Schmidt P; Haas RJ;
    Onkologie; 2002 Feb; 25(1):14-22. PubMed ID: 11893878
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic factors in yolk sac tumors of the ovary. A clinicopathologic analysis of 29 cases.
    Kawai M; Kano T; Furuhashi Y; Mizuno K; Nakashima N; Hattori SE; Kazeto S; Iida S; Ohta M; Arii Y
    Cancer; 1991 Jan; 67(1):184-92. PubMed ID: 1845936
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Actual half-life of alpha-fetoprotein as a prognostic tool in pediatric malignant tumors.
    Han SJ; Yoo S; Choi SH; Hwang EH
    Pediatr Surg Int; 1997; 12(8):599-602. PubMed ID: 9354734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.